[BREAKING NEWS] SUCCESS! Gilead's Remdesivir Succeeded in Critical Trial Against COVID-19, Raising Hopes for a Coronavirus Cure Biotech company Gilead shared some good news as remdesivir, one of the leading candidates for COVID-19 cure, succeeded in a crucial trial. by Nhx Tingson
Health Pharma Giant Gilead Retracts Orphan Drug Status After Allegedly Trying to Monopolize Coronavirus Cure by Urian B.
Healthy Living/Wellness Federal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute by Catherine Cabral-Isabedra
Healthy Living/Wellness Expensive hepatitis C drug Sovaldi to be made cheaper in developing countries by Sumit Passary
Healthy Living/Wellness Hepatitis C drug Sovaldi gets NICE approval despite being pricey by Lori Sandoval